Top Markets
Coin of the day
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Peringkat dalam Saham #25837
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Harga Saham
$0.74834668
Terakhir disinkronkan: 2026-08-20
Kapitalisasi Pasar
$45.86M
Perubahan (1 hari)
-0.15%
Perubahan (1 tahun)
-2.71%
Negara
SE
Perdagangan Mendus AB (publ) (IMMU)

Kategori

Riwayat harga saham Mendus AB (publ) (IMMU)
Harga penutupan tertinggi: $0.75 pada 2026-08-01

Harga penutupan terendah: $1.01 pada 2013-04-01
Riwayat harga saham Mendus AB (publ) dari 2013 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 14.30%
2025 -29.72%
2024 -32.55%
2023 -76.95%
2022 -39.21%
2021 -55.05%
2020 -17.38%
2019 29.23%
2018 -11.66%
2017 -59.00%
2016 -42.62%
2015 63.38%
2014 -42.62%
2013 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US